Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins.
Carmi S, Hui KY, Kochav E, Liu X, Xue J, Grady F, Guha S, Upadhyay K, Ben-Avraham D, Mukherjee S, Bowen BM, Thomas T, Vijai J, Cruts M, Froyen G, Lambrechts D, Plaisance S, Van Broeckhoven C, Van Damme P, Van Marck H, Barzilai N, Darvasi A, Offit K, Bressman S, Ozelius LJ, Peter I, Cho JH, Ostrer H, Atzmon G, Clark LN, Lencz T, Pe'er I.
Nat Commun
5 :
2014
4835
91
Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.
Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, Mayeux R, Shelanski M, Di Paolo G, Lee JH.
PLoS One
10 :
2015
e0125204
31
Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews.
Streicher SA, Klein AP, Olson SH, Amundadottir LT, DeWan AT, Zhao H, Risch HA.
Cancer Epidemiol Biomarkers Prev
26 :
2017
1540-1548
4
High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation.
Lencz T, Yu J, Palmer C, Carmi S, Ben-Avraham D, Barzilai N, Bressman S, Darvasi A, Cho JH, Clark LN, Gümüş ZH, Joseph V, Klein R, Lipkin S, Offit K, Ostrer H, Ozelius LJ, Peter I, Atzmon G, Pe'er I.
Hum Genet
137 :
2018
343-355
15
Novel ultra-rare exonic variants identified in a founder population implicate cadherins in schizophrenia.
Lencz T, Yu J, Khan RR, Flaherty E, Carmi S, Lam M, Ben-Avraham D, Barzilai N, Bressman S, Darvasi A, Cho JH, Clark LN, Gümüş ZH, Vijai J, Klein RJ, Lipkin S, Offit K, Ostrer H, Ozelius LJ, Peter I, Malhotra AK, Maniatis T, Atzmon G, Pe'er I.
Neuron
109 :
2021
1465-1478.e4
10
Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14<sup>th</sup> century.
Waldman S, Backenroth D, Harney É, Flohr S, Neff NC, Buckley GM, Fridman H, Akbari A, Rohland N, Mallick S, Olalde I, Cooper L, Lomes A, Lipson J, Cano Nistal J, Yu J, Barzilai N, Peter I, Atzmon G, Ostrer H, Lencz T, Maruvka YE, Lämmerhirt M, Beider A, Rutgers LV, Renson V, Prufer KM, Schiffels S, Ringbauer H, Sczech K, Carmi S, Reich D.
Cell
185 :
2022
4703-4716.e16
3
The predictive capacity of polygenic risk scores for disease risk is only moderately influenced by imputation panels tailored to the target population.
Levi H, Elkon R, Shamir R.
Bioinformatics
40 :
2024
btae036
0
